Navigation Links
FDA Approves New Type 2 Diabetes Drug

FRIDAY, Aug. 1, 2014 (HealthDay News) -- The U.S. Food and Drug Administration announced on Friday that it approved a new drug, Jardiance, to help fight type 2 diabetes.

Jardiance (empagliflozin) "can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of diabetes," Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research, said in an agency statement.

The FDA also recommended that Jardiance be used along with lifestyle changes, such as eating a healthy diet and exercising regularly. The combination of medication and lifestyle modification may improve blood sugar management for people with type 2 diabetes, they said.

Over 26 million Americans are currently affected by type 2 diabetes, which accounts for about 90 percent of cases of diabetes, according to the agency.

Jardiance, made by Connecticut-based Boehringer Ingelheim Pharmaceuticals, falls into the class of diabetes medicines known as "sodium glucose co-transporter 2 (SGLT2) inhibitors." These drugs work by stopping blood sugar, or glucose, from getting reabsorbed by the kidneys. That means that more glucose is excreted by the kidneys and blood sugar levels go down, the FDA explained. Other drugs in this class of medications include Invokana (canagliflozin) and Farxiga (dapagliflozin).

The agency said the safety and effectiveness of Jardiance was tested in seven clinical trials involving almost 4,500 people with type 2 diabetes. The studies showed that Jardiance improved blood sugar levels compared to a "dummy" placebo drug.

The drug has also been studied for use alongside other medications, such as metformin, sulfonylureas, pioglitazone (Actos) and insulin. The FDA stressed that it is ordering post-marketing studies on Jardiance, with a focus on any potential cardiovascular effects, as well as safety and effectiveness in children.

Jardiance can trigger dehydration, which can cause low blood pressure, dizziness and impaired kidney function, the FDA added. This means that elderly people and those with already impaired kidney function may be at heightened risk when taking Jardiance. The drug should not be used by people with type 1 diabetes, according to the FDA.

The most common side effects seen with Jardiance included urinary tract infections and female genital infections, the FDA said.

More information

Find out more about type 2 diabetes at the American Diabetes Association.

SOURCE: U.S. Food and Drug Administration, news release, Aug. 1, 2014


Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Approves Generic Versions of Plavix
2. FDA Approves Combo Shot for Meningitis, Hib in Kids
3. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
4. FDA Approves First New Weight-Loss Drug in More Than a Decade
5. FDA Approves 1st Pill to Help Prevent HIV Infection
6. FDA Approves 2nd New Weight-Loss Drug
7. FDA Approves Flu Vaccine for Coming Season
8. FDA Approves New Once-a-Day HIV Pill
9. FDA Approves New Type of Flu Vaccine
10. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
11. FDA Approves 1st Skin Patch to Combat Migraines
Post Your Comments:
Related Image:
FDA Approves New Type 2 Diabetes Drug
(Date:11/30/2015)... ... ... Bayco Products, Inc today announced the introduction of three Nightstick® brand LED traffic wands with ... colors; red ( NSP-1632 ), yellow ( NSP-1634 ) and blue ( NSP-1636 ), the ... or 27 hours in blinking strobe mode using a fresh set of 3 AAA cells ...
(Date:11/29/2015)... Metamora, Michigan (PRWEB) , ... ... ... is once again accredited by the American Institute of Ultrasound in Medicine! ... allows practices to demonstrate that they meet or exceed nationally recognized standards ...
(Date:11/29/2015)... ... November 29, 2015 , ... NewsWatch featured X-wing as ... available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted ... reality in the future. , It’s the future because flying cars are about to ...
(Date:11/29/2015)... , ... November 29, 2015 , ... Doctors who missed ... colleagues to recognize the signs of mesothelioma and push for a diagnosis, especially in ... its website. Click here to read it now. , Researchers at ...
(Date:11/29/2015)... ... November 29, 2015 , ... Key Housing, a top-rated ... announce their December, 2015, featured apartment community: Epic. In showcasing this featured apartment community ... the tight Bay Area rental market to efficiently find housing suitable to their needs ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... Iowa , Nov. 29, 2015 ... ultrasound guidance technology at the Radiological Society of ... in Chicago November 29 ... system is designed to offer customers unrivaled versatility, ... --> ...
(Date:11/27/2015)... 27, 2015 Ein neuer ... Krebs.   --> Ein neuer Kombinationsansatz ...   --> Ein neuer Kombinationsansatz ...   Clinical Cancer Research vom ... Cancer Research vom 6. November 2015 berichtet. ...
(Date:11/26/2015)... PUNE, India , November ... --> ... / personal emergency response system ... grow steadily for 5 years ... growing region expected to see ...
Breaking Medicine Technology: